Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration

PURPOSE: The use of anti-vascular endothelial growth factor (anti-VEGF) therapy, with drugs such as ranibizumab and bevacizumab, to treat neovascular age-related macular degeneration (nAMD) produces an effective but widely variable response. Identifying markers that predict differentiated response c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Vinson M., Rosen, Richard B., Meyerle, Catherine B., Kurup, Shree K., Ardeljan, Daniel, Agron, Elvira, Tai, Katy, Pomykala, Matthew, Chew, Emily Y., Chan, Chi-Chao, Tuo, Jingsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482167/
https://www.ncbi.nlm.nih.gov/pubmed/23112570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482167/
https://www.ncbi.nlm.nih.gov/pubmed/23112570

Ejemplares similares